Company Filing History:
Years Active: 2013
Title: Innovations of Chuangui Huang in Pharmaceutical Chemistry
Introduction
Chuangui Huang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of compounds. His research focuses on enhancing the stability and usability of pharmaceutical formulations.
Latest Patents
Chuangui Huang holds a patent for the crystalline form I of 3,4',5-trihydroxy-stilbene-3-β-D-glucoside, commonly known as polydatin. This invention relates to a novel crystalline form of the compound and includes a method of preparation and use. The crystalline form I exhibits a stable morphology, a defined melting point, and good chemical stability. These properties are essential for the preparation of solid formulations, allowing for reduced raw material costs and improved production efficiency. The invention also facilitates better quality control in industrial drug production and enhances storage convenience.
Career Highlights
Chuangui Huang is associated with Shenzhen Neptunus Pharmaceutical Holdings Co., Ltd., where he applies his expertise in pharmaceutical development. His work has contributed to advancements in drug formulation and production processes, making a significant impact in the pharmaceutical industry.
Collaborations
Chuangui Huang collaborates with esteemed colleagues, including Hui Kang and Jinhua Zhao. Their combined efforts in research and development have fostered innovation in pharmaceutical chemistry.
Conclusion
Chuangui Huang's contributions to the field of pharmaceutical chemistry, particularly through his patented innovations, demonstrate his commitment to advancing drug formulation and production. His work not only enhances the stability and usability of pharmaceutical compounds but also contributes to the efficiency of drug manufacturing processes.